Clinical trial
Efficacy of Rupatadine 5, 10 and 20 mg in Chronic Idiopathic Urticaria
NCT00199238 · J. Uriach and Company, Industry · Terminated
Key facts
| NCT number | NCT00199238 |
|---|---|
| Title | Efficacy of Rupatadine 5, 10 and 20 mg in Chronic Idiopathic Urticaria |
| Official title | A 4-week Dose-finding, Multicentre, Double-blind, Randomised, Placebo-controlled, Parallel-group Trial to Assess the Efficacy and Safety of Different Doses of Rupatadine Compared to Placebo in the Treatment of Chronic Idiopathic Urticaria |
| Lead sponsor | J. Uriach and Company, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | URTICARIA |
| Intervention type | Drug |
| Interventions | Rupatadine Fumarate |
| Enrollment | 248 |
| Start date | Oct 28, 2002 |
| Primary completion | Nov 25, 2003 |
| Completion | Sep 27, 2004 |
| First posted | Sep 20, 2005 |
| Last update posted | Feb 18, 2022 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: